Given that significant infiltration of immune cells such as macrophages, microglia, monocytes, lymphocyte, and neutrophils is linked to poor prognosis in many cancer types, these disrupted immune infiltrates in IDH1 mutation glioma tumors may contribute to the different aggressiveness of these two glioma types. The gene discussed is IDH1; the disease is glioma.